$3.13
-0.015-0.48%
Last update: Oct 27, 9:30 AM
LENZ Therapeutics Inc (LENZ) Stock Price, Quote, News & History
LENZNASDAQ
FDA approved Tenpoint's Yuvezzi eye drop for presbyopia, adding competition for LENZ's VIZZ as analysts say the recent stock drop may be overdone and see...
You can purchase shares of LENZ Therapeutics (NASDAQ:LENZ) through any online brokerage.
Other companies in LENZ Therapeutics’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
LENZ Therapeutics has a consensus price target of $32.50.
The stock price for LENZ Therapeutics (NASDAQ: LENZ) is $3.13 last updated October 27, 2026 at 9:30 AM EDT.
There are no upcoming dividends for LENZ Therapeutics.
LENZ Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for LENZ Therapeutics.
LENZ Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a...
